A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration

8.7K views

⸱

DOI:

10.3791/54002

⸱

May 13th, 2016

 ,  , 
1School of Biology, Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology

In This Article

Summary

Sustained fibrosis with deposition of excessive extracellular matrix proteins leads to cirrhosis. Alcohol abuse is one of the main causes of severe liver disease. We established an ethanol-induced zebrafish fibrotic liver model to study the mechanisms and strategies of promoting hepatocyte regeneration upon alcohol-induced injury.

Abstract

Sustained liver fibrosis with continuation of extracellular matrix (ECM) protein build-up results in the loss of cellular competency of the liver, leading to cirrhosis with hepatocellular dysfunction. Among multiple hepatic insults, alcohol abuse can lead to significant health problems including liver failure and hepatocellular carcinoma. Nonetheless, the identity of endogenous cellular sources that regenerate hepatocytes in response to alcohol has not been properly investigated. Moreover, few studies have effectively modeled hepatocyte regeneration upon alcohol-induced injury. We recently reported on establishing an ethanol (EtOH)-induced fibrotic liver model in zebrafish in which hepatic progenitor cells (HPCs) gave rise to hepatocytes upon near-complete hepatocyte loss in the presence of fibrogenic stimulus. Furthermore, through chemical screens using this model, we identified multiple small molecules that enhance hepatocyte regeneration. Here we describe in detail the procedures to develop an EtOH-induced fibrotic liver model and to perform chemical screens using this model in zebrafish. This protocol will be a critical tool to delineate the molecular and cellular mechanisms of how hepatocyte regenerates in the fibrotic liver. Furthermore, these methods will facilitate potential discovery of novel therapeutic strategies for chronic liver disease in vivo.

Introduction

Despite the remarkable regeneration capacity of hepatocytes1, which are the major parenchymal cell type of the liver, chronic liver failure impairs this ability, leading to hepatic progenitor cell (HPC)-dependent regeneration2.

Chronic liver damage is mainly derived from alcohol abuse, chronic hepatitis C virus (HCV) infection3 and non-alcoholic fatty liver disease (NAFLD)4. It leads to sustained liver fibrosis, which is associated with the accumulation of extracellular matrix (ECM) proteins. Persisting ECM accumulation distorts intact hepatic architecture by forming a fibrous scar tissue5, subsequently resulting in cirrhosis with high morbidity and mortality. Many attempts have been made to mitigate the fibrotic response mainly by focusing on inhibiting profibrogenic cytokines and activated myofibroblasts6. The latter is primarily derived from hepatic stellate cells (HSCs), the principle hepatic non-parenchymal cells responsible for liver scar formation4. Nevertheless, regenerative therapies that stimulate endogenous cellular sources including HPCs to regenerate hepatocytes in the presence of sustained fibrogenic insults await further investigation.

Many experimental models of hepatic fibrosis have been described in mammals. Repetitive injection of carbon tetrachloride (CCl4) has been widely used to induce liver fibrosis in murine and rat models7. When combined with a high-fat (HF) diet, alcohol led to a substantial upregulation of profibrogenic gene expression and hepatic fibrosis8. While steatosis (lipid accumulation) results from acute alcohol exposure, it makes the liver susceptible to more severe hepatic injury9.

The zebrafish, Danio rerio, has emerged as an invaluable vertebrate model system for studying regeneration. Though other lower vertebrates such as newts and axolotls have a remarkable capacity for regeneration, the zebrafish has advantages over other model systems in regards to the gene manipulation and visualization strategies needed to manipulate potential regenerative factors10. The zebrafish also represents an attractive vertebrate model for studying alcoholic liver disease (ALD) by simply adding ethanol (EtOH) to their water. Acute EtOH exposure to larval and adult zebrafish caused hepatic steatosis11-13. When adult zebrafish received extended EtOH exposure, collagen deposition was observed with upregulation of fibrosis-related genes14. However, a need exists for developing models to study liver regeneration in response to EtOH as a fibrogenic stimulus.

Recently, we developed an EtOH-induced fibrotic liver model in zebrafish15. We combined a hepatocyte-specific genetic ablation system with EtOH treatment in larval and adult zebrafish. We generated two transgenic lines, Tg(fabp10a:CFP-NTR)gt1 and Tg(fabp10a:mCherry-NTR)gt2, in which E.coli nitroreductase (NTR) are fused to the cyan and mCherry fluorescent protein, respectively, under the control of the hepatocyte-specific fatty acid binding protein 10a, liver basic (fabp10a) promoter. In this system, NTR converts a nontoxic prodrug metronidazole (MTZ) into a DNA inter-strand cross-linking agent16, inducing explicit death of hepatocytes. Using this model, we demonstrated that a population of hepatic cells, which are responsive to Notch signaling, converted into hepatocytes in the near absence of hepatocytes and in the excess of ECM. We designated these cells as HPCs. Furthermore, through chemical screens, we identified small molecule activators of Wnt signaling and inhibitors of Notch signaling that augment hepatocyte regeneration in the fibrotic liver. Therefore, our fibrotic liver model in zebrafish represents a superb chemical screening system compared to cell culture- or mammalian-based screening system. It is an in vivo system with significant cost- and time-saving benefits. Here we describe the detailed procedures for establishing an EtOH-induced fibrotic liver model and for performing chemical screens using this model in zebrafish. Furthermore, time-course analyses were performed to investigate how hepatocyte regeneration occurs in the fibrotic liver. This protocol will provide an invaluable tool to study the mechanisms and strategies of enhancing hepatocyte regeneration in the fibrotic liver.

Access restricted. Please log in or start a trial to view this content.

Protocol

Zebrafish were raised and bred using a standard protocol that meets the criteria of the National Institutes of Health and approved by the Georgia Institute of Technology Institutional Animal Care and Use Committee. 

1. Preparation of Solutions

  1. Prepare 20 L egg water (interchangeably used with ‘embryo medium’)  to maintain embryonic/larval zebrafish. Dissolve 1.5 g CaSO4 and 6 g instant ocean sea salt in 250 ml distilled water. Pour into a carboy filled with 20 L distilled water and agitate.
  2. Prepare 1 L 1-phenyl-2-thiourea (PTU) stock solution (20x). Dissolve 0.6 g PTU powder in 1 L distilled water. Add 1 ml of stock solution per 20 ml embryo medium to a final concentration of 0.003% as a working solution.
    CAUTION: PTU may cause systemic toxicity following inhalation or dermal exposure. Prepare and use in accordance with appropriate handling guidelines.
  3. Prepare 1 L ethyl 3-aminobenzoate methanesulfonate (Tricaine) stock solution (20x). Dissolve 4 g Tricaine powder in distilled water. Adjust pH to 7 by adding 1 M Tris buffer (pH 9), and bring the final volume to 1 L with distilled water. Aliquot into 50 ml and store at -20 °C. Thaw before use.
    CAUTION: Tricaine can induce a loss of sensation. Prepare and use in accordance with appropriate handling guidelines.
  4. Prepare 100 ml larval metronidazole (MTZ) working solution. Make fresh 15 mM MTZ solution by dissolving 0.25 g MTZ powder in 0.1% dimethyl sulfoxide (DMSO) in 100 ml embryo medium. Dissolve MTZ powder completely by vigorous shaking. Make fresh MTZ solution and use aluminum foil to prevent photocatalytic degradation of MTZ.
    CAUTION: MTZ may cause irritation. Prepare and use in accordance with appropriate handling guidelines.
  5. Prepare 100 ml larval ethanol/metronidazole (EtOH/MTZ) working solution. Make fresh MTZ solution and use aluminum foil to prevent photocatalytic degradation of MTZ. Add 1.5 ml 100% ethanol into 100 ml MTZ solution to a final concentration of 1.5% just before use.
  6. Prepare 500 ml adult MTZ working solution. Make fresh 10 mM MTZ solution by dissolving 0.83 g MTZ powder in 0.1% DMSO in 500 ml system water. Dissolve MTZ powder completely by vigorous shaking. Make fresh MTZ solution and use aluminum foil to prevent photocatalytic degradation of MTZ.
  7. Prepare 1 L PEM buffer. Dissolve 30.2 g PIPES, 0.74 g EGTA, and 0.12 g MgSO4 in distilled water. Adjust pH to 7 with NaOH. Bring final volume to 1 L with distilled water.

2. Preparation of Larval Zebrafish

  1. Set up mating of [Tg(fabp10a:CFP-NTR)gt1; Tg(Tp1:mCherry)jh11]15,17 adult zebrafish with Tg(hand2:EGFP)pd24 13 adult zebrafish in mating tanks. Use dividers to conduct timed mating.
  2. Remove the divider the following morning and allow fish to mate without disruption. Harvest embryos 2 hr later by straining system water and transferring the embryos into 100 mm Petri dishes with embryo medium.
  3. Keep no more than 100 embryos per Petri dish. Under a stereomicroscope, remove unfertilized eggs using a glass pipette. Grow embryos at 28 °C and add phenylthiourea (PTU) to a final concentration of 0.003% after 10 hours-post-fertilization (hpf) to inhibit pigment development.

3. Ethanol, Metronidazole Treatment and Liver Regeneration in Larval Zebrafish

  1. Prepare fresh EtOH solution by adding ethanol into embryo medium to a final concentration of 1.5%. Do not add PTU.
  2. Treat embryos with 20 ml ethanol solution per Petri dish from 56 to 80 hpf. Cover Petri dishes with plastic wrap to prevent ethanol evaporation.
  3. Sort out [Tg(fabp10a:CFP-NTR)gt1; Tg(Tp1:mCherry)jh11; Tg(hand2:EGFP)pd24] larvae with similar liver size, as determined by CFP expression, at 80 hpf. Do not use Tricaine when sorting the EtOH-treated larvae because this will cause high mortality rate with subsequent EtOH/MTZ treatment. Keep sorted larvae at a density of 30 embryos per Petri dish.
  4. Prepare fresh 15 mM MTZ in embryo medium in 0.1% DMSO. Add proper amount of EtOH into MTZ solution to make a final concentration of 1.5%. Incubate larvae in 20 ml EtOH/MTZ solution per Petri dish for 24 hr at 28 °C. Cover Petri dishes with plastic wrap to maintain EtOH concentration and with aluminum foil to protect from light.
  5. At the end of the treatment, remove EtOH/MTZ solution by transferring larvae to new Petri dishes with fresh embryo medium. Wash larvae 3 times with embryo medium and keep them in 20 ml embryo medium without PTU.
  6. To sort out the larvae with near-complete ablation of hepatocytes, observe fluorescence under an epifluorescence microscope with the CFP filter at a magnification of 80X. Successful ablation results in minimal CFP fluorescence in the liver and significantly reduced liver volume.
  7. To avoid death of the EtOH/MTZ-treated larvae, do not use Tricaine for sorting. Fix the larvae for immunostaining (refer to section 5) or keep sorted larvae in Petri dishes at 28 °C for further analyses.

4. Chemical Screens in EtOH/MTZ-treated Larval Zebrafish

  1. Bring the 96-well plates containing 10 mM chemical stocks in DMSO (refer to the Materials List for details regarding the commercial chemical libraries) from the -80 °C freezer. Cover with aluminum foil to prevent photocatalytic degradation of chemicals. Thaw the stock solutions at RT with gentle rocking.
  2. Prepare chemical solutions by diluting  10 mM stock solutions with embryo medium to a final concentration of 50 µM (in 96 well plates: initial screen; in 1.5 ml tubes: retesting). Control larvae were treated with equal concentrations of DMSO in embryo medium. 
  3. Transfer larvae with near-complete hepatocyte ablation, which were treated with 1.5% EtOH/15 mM MTZ and sorted as aforementioned, to either 96-well (initial screen) or 24-well (retesting)  plates prefilled with embryo medium at a density of 5 larvae per well. Use duplicate wells for each chemical.
  4. Remove embryo medium and add either 250 µl (96-well plates) or 500 µl (24-well plates)  chemical solutions to each well. Cover plates with aluminum foil and treat larvae for 50 hr at 28 °C. Inspect chemical-soaking larvae daily and remove any dead larvae from individual wells.
  5. At the end of the chemical treatment, observe the number and/or intensity of CFP-expressing hepatocytes under an epifluorescence microscope with the CFP filter at a magnification of 80X. Photograph live larvae showing enhanced or reduced number and/or intensity of CFP-expressing hepatocytes with a digital camera for records.
  6. Preserve larvae by formaldehyde fixation for confocal imaging as described in section 5.
  7. To retest the chemicals that facilitate hepatocyte regeneration in the initial screen, examine their potency at higher and lower concentrations to find the most efficacious concentration with the procedures described in 4.1-4.5 ('retesting').

5. Larval Zebrafish Fixation, Immunostaining, and Confocal Imaging

  1. Anesthetize larvae by adding Tricaine to a final concentration of 0.02%. Transfer 10-15 larvae to a 1.5 ml tube and wash once with phosphate-buffered saline (PBS). Remove PBS and add 1 ml of freshly prepared 2% formaldehyde in PEM buffer to fix O/N at 4 °C.
    CAUTION: Formaldehyde causes irritation and is known to be a human carcinogen. Handle in a chemical fume hood.
  2. Discard fixing solution properly and then wash 3 times with PBS at RT. Fixed larvae can be kept in PBS at 4 °C for up to several days. Proceeding to the next step promptly gives better immunostaining results.
  3. Carefully remove yolk and skin covering the liver area using a #55 forceps under a stereomicroscope.
  4. Permeabilize and block larvae in Block buffer (4% bovine serum albumin and 0.3% Triton X-100 in PBS) O/N at 4 °C.
  5. Incubate with rabbit anti-Collagen I antibody at a dilution of 1:100 in Block buffer O/N at 4 °C. Wash 5 times for 15 min each with Wash buffer (0.3% Triton X-100 in PBS).
  6. Incubate with AlexaFluor 647 conjugated donkey anti-rabbit antibody at a dilution of 1:200 in Block buffer O/N at 4 °C. Wash 5 times for 15 min each with Wash buffer. Then wash once with PBS.
  7. Gently transfer larvae to glass slides using a glass pipette, and orient fixed larvae with the left lateral side facing up. Remove excess PBS using Kimwipes. Add a drop of mounting media, and seal cover glass with nail polish. Conducting confocal imaging immediately is greatly recommended.
  8. Use a confocal system equipped with a 40X/1.3 oil lens to capture images. Use laser strength at 20-50%. Capture Z stack images at 1 µm intervals.

6. Preparation of Adult Zebrafish

  1. Set up mating of [Tg(fabp10a:CFP-NTR)gt1; Tg(Tp1:mCherry)jh11]15,17 adult zebrafish in mating tanks. Harvest embryos the next morning by straining system water and transferring the embryos into 100 mm Petri dishes with embryo medium.
  2. Keep no more than 100 embryos per Petri dish. Under a stereomicroscope, remove unfertilized eggs using a glass pipette. Grow embryos at 28 °C and add PTU to a final concentration of 0.003% after 10 hpf to inhibit pigment development.
  3. At 4 dpf, use Tricaine to anesthetize larvae and sort out [Tg(fabp10a:CFP-NTR)gt1; Tg(Tp1:mCherry)jh11] larvae. Wash out Tricaine by changing to fresh embryo medium several times. Allow larvae to recover at 28 °C until they achieve normal heart rate of 120-180 beats per minute18.
  4. Raise sorted larvae to 6-12 months old based on the standard procedure19.

7. Ethanol, Metronidazole Treatment, and Liver Regeneration in Adult Zebrafish

  1. Transfer 6-12 months old [Tg(fabp10a:CFP-NTR)gt1; Tg(Tp1:mCherry)jh11] adult zebrafish to mating tanks using a net. Keep fish at a density of no more than 10 fish per tank.
  2. Prepare fresh EtOH solution by adding EtOH in system water to a final concentration of 1%. Treat adult fish with 500 ml EtOH solution in each tank and maintain them in a 28 °C incubator.
  3. Transfer adult fish to fresh EtOH solution daily, discard dead fish properly as a biohazard. Continuously treat animals for 72 hr before MTZ treatment.
  4. Prepare fresh 10 mM MTZ solution in system water in 0.1% DMSO. Pre-warm the MTZ solution in a 28 °C incubator. Treat fish with 500 ml MTZ solution in 1 L crossing tank for 8 hr at 28 °C, protect from light using aluminum foil.
  5. Observe hourly during the treatment and remove dead fish immediately. Discard dead fish properly as a biohazard. At the end of the MTZ treatment, wash out MTZ by transferring animals to fresh system water twice.
  6. Allow animals to recover and maintain them in an incubator at 28 °C. Feed and transfer fish to fresh system water daily until the time point for analyses.

8. Adult Zebrafish Liver Fixation, Immunostaining, and Confocal Imaging 

  1. Anesthetize adult fish with 0.02% Tricaine and euthanize in ice water for 15 min. Pat the fish dry on a paper towel and place it on a dissecting mat.
  2. Expose gastrointestinal organs by removing skin and muscles as previously described20. Use scissors to cut the skin and underlying muscle along the belly from the anal fin to the operculum, and then posteriorly along the side of the fish back to the anal fin.
  3. Put the fish in a 15 ml conical tube and wash once with PBS. Remove PBS and add 4 ml of freshly prepared 2% formaldehyde in PEM buffer to fix O/N at 4 °C.
  4. Discard fixing solution properly, and wash 3 times with PBS at RT. Fixed samples can be kept in PBS at 4 °C for several days. Proceeding to the next step immediately gives better immunostaining results.
  5. Dissect the whole gut with liver from the body cavity of the fish by cutting the esophagus. Embed the gastrointestinal organs with 4% low-melting agarose in a sectioning mold.
  6. Use a vibratome to cut samples into transverse sections at 50 µm intervals in ice cold PBS, starting from the anterior end. Transfer sections to 6-well plate with PBS using a #1 paint brush.
  7. Permeabilize and block sections in Block buffer O/N at 4 °C.
  8. Incubate with rabbit anti-Collagen I antibody at a dilution of 1:100 in Block buffer O/N at 4 °C. Wash 5 times, 15 min each with Wash buffer.
  9. Incubate with AlexaFluor 647 conjugated donkey anti-rabbit antibody at a dilution of 1:200 in Block buffer O/N at 4 °C. Wash 5 times, 15 min each with Wash buffer and once with PBS.
  10. Gently transfer sections to glass slides using a #1 paint brush. Remove excess PBS using Kimwipes, add a drop of mounting media, and seal cover glass with nail polish. Conducting confocal imaging immediately is highly suggested.
  11. Use a confocal system equipped with a 40X/1.3 oil lens to capture images. Use laser strength at 20-50%. Capture Z stack images at 1 µm intervals.

Access restricted. Please log in or start a trial to view this content.

Results

Figure 1 shows the development of an EtOH-induced fibrotic liver model in larval zebrafish. To optimize a protocol for exposing zebrafish larvae to EtOH, we first assessed EtOH toxicity. 2.5 days-post-fertilization (dpf) larvae were exposed to EtOH concentration 1%, 1.5%, or 2% for 24 hr followed by a concurrent 24 hr EtOH/MTZ treatment. Exposure to 2% EtOH caused high mortality, while nearly all larvae exposed to 1% EtOH or less showed minimal fibrogenic changes with rar...

Access restricted. Please log in or start a trial to view this content.

Discussion

We observed HPC-mediated hepatocyte regeneration in the EtOH/MTZ-treated recovering livers, suggesting that even in the presence of substantial amount of ECM proteins including fibrillar type I collagen, the HPCs retain their competency to regenerate as hepatocytes. The MTZ only-treatment did not increase deposition of ECM proteins significantly, whereas the EtOH only-treatment did not induce HPC activation15. By utilizing the combined EtOH/MTZ treatment, we were able to investigate HPC-driven regeneration in ...

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare that they have no competing financial interests.

Acknowledgements

This work was supported in part by grants from the GTEC (2731336 and 1411318), the NIH (K01DK081351), and the NSF (1354837) to C. H. S. We thank Alem Giorgis for critical reading of the manuscript.

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Calcium sulfate hemihydrate (CaSO4)AcrosAC385355000
Magnesium sulfate (MgSO4)EMDMX0075
1,4-Piperazinediethanesulfonic acid (PIPES)Sigma-AldrichP6757
Ethylene glycol-bis(2-aminoethylether)-
N,N,N′,N′-tetraacetic acid (EGTA)		Sigma-AldrichE3889
EthanolSigma-AldrichE7023200 proof
FormaldehydeFisher ScientificF79-500
Metronidazole (MTZ)Sigma-AldrichM3761
1-phenyl-2-thiourea (PTU)Sigma-AldrichP7629
3-amino benzoic acid ethyl ester (Tricaine)Sigma-AldrichA5040
Phosphate-buffered saline (PBS) tabletAmrescoE404Dissolve one tablet with 100 ml distilled water
Dimethyl sulfoxide (DMSO)Sigma-AldrichD2438
Bovine serum albuminFisher ScientificBP1600
Triton X-100Fisher ScientificBP151
Low-melting agarose AmrescoBP165
Stem Cell Signaling Compound LibrarySelleck ChemicalsL210010 mM stock in DMSO
ActiProbe-1K LibraryTimtecActiProbe-1K10 mM stock in DMSO
SB 415286Selleck ChemicalsS2729Dissolve with DMSO to 10 mM
CHIR-99021Selleck ChemicalsS2924Dissolve with DMSO to 10 mM
Anti-Collagen I antibodyAbcamab23730Use at 1:100 for immunostaining, reacts with fish
AlexaFluor 647 Donkey anti-rabbit IgG (H+L)Molecular ProbesA31573Use at 1:200 for immunostaining
Mounting media (Vectorshield)Vector LaboratoriesH-1400
100 mm Petri dishVWR25384-088
24-well plateVWR10062-896
ForcepsFine Science Tools11255-20Dumont #55
Glass slideVWR48312-00375x25 mm
Cover glassVWR48366-04518 mm
Plastic wrapFisher Scientific22305654
Aluminum foilFisher Scientific1213100
KimwipesKimberly-Clark34155
VibrotomeLeicaVT1000 S
Stereo microscopeLeicaM80
Epifluoresence microscopeLeicaM205 FA
Confocol microscopeZeissLSM700

References

  1. Michalopoulos, G. K. Liver regeneration. J Cell Physiol. 213 (2), 286-300 (2007).
  2. Duncan, A. W., Dorrell, C., Grompe, M. Stem cells and liver regeneration. Gastroenterology. 137 (2), 466-481 (2009).
  3. Shepard, C. W., Finelli, L., Alter, M. J. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 5 (9), 558-567 (2005).
  4. Hernandez-Gea, V., Friedman, S. L. Pathogenesis of liver fibrosis. Annu Rev Pathol. 6, 425-456 (2011).
  5. Bataller, R., Brenner, D. A. Liver fibrosis. J Clin Invest. 115 (2), 209-218 (2005).
  6. Kisseleva, T., Brenner, D. A. Anti-fibrogenic strategies and the regression of fibrosis. Best Pract Res Clin Gastroenterol. 25 (2), 305-317 (2011).
  7. Constandinou, C., Henderson, N., Iredale, J. P. Modeling liver fibrosis in rodents. Methods Mol Med. 117, 237-250 (2005).
  8. Gabele, E., et al. A new model of interactive effects of alcohol and high-fat diet on hepatic fibrosis. Alcohol Clin Exp Res. 35 (7), 1361-1367 (2011).
  9. Lieber, C. S. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol. 34 (1), 9-19 (2004).
  10. Poss, K. D. Advances in understanding tissue regenerative capacity and mechanisms in animals. Nat Rev Genet. 11 (10), 710-722 (2010).
  11. Jang, Z. H., et al. Metabolic profiling of an alcoholic fatty liver in zebrafish (Danio rerio). Mol Biosyst. 8 (7), 2001-2009 (2012).
  12. Passeri, M. J., Cinaroglu, A., Gao, C., Sadler, K. C. Hepatic steatosis in response to acute alcohol exposure in zebrafish requires sterol regulatory element binding protein activation. Hepatology. 49 (2), 443-452 (2009).
  13. Yin, C., Evason, K. J., Maher, J. J., Stainier, D. Y. The basic helix-loop-helix transcription factor, heart and neural crest derivatives expressed transcript 2, marks hepatic stellate cells in zebrafish: analysis of stellate cell entry into the developing liver. Hepatology. 56 (5), 1958-1970 (2012).
  14. Lin, J. N., et al. Development of an animal model for alcoholic liver disease in zebrafish. Zebrafish. 12 (4), 271-280 (2015).
  15. Huang, M., et al. Antagonistic interaction between Wnt and Notch activity modulates the regenerative capacity of a zebrafish fibrotic liver model. Hepatology. 60 (5), 1753-1766 (2014).
  16. Curado, S., Stainier, D. Y., Anderson, R. M. Nitroreductase-mediated cell/tissue ablation in zebrafish: a spatially and temporally controlled ablation method with applications in developmental and regeneration studies. Nat Protoc. 3 (6), 948-954 (2008).
  17. Parsons, M. J., et al. Notch-responsive cells initiate the secondary transition in larval zebrafish pancreas. Mech Dev. 126 (10), 898-912 (2009).
  18. Baker, K., Warren, K. S., Yellen, G., Fishman, M. C. Defective 'pacemaker' current (Ih) in a zebrafish mutant with a slow heart rate. Proc Natl Acad Sci U S A. 94 (9), 4554-4559 (1997).
  19. Avdesh, A., et al. Regular care and maintenance of a zebrafish (Danio rerio) laboratory: an introduction. J Vis Exp. (69), e4196(2012).
  20. Gupta, T., Mullins, M. C. Dissection of organs from the adult zebrafish. J Vis Exp. (37), (2010).
  21. Paku, S., Schnur, J., Nagy, P., Thorgeirsson, S. S. Origin and structural evolution of the early proliferating oval cells in rat liver. Am J Pathol. 158 (4), 1313-1323 (2001).
  22. Turner, R., et al. Human hepatic stem cell and maturational liver lineage biology. Hepatology. 53 (3), 1035-1045 (2011).
  23. Kodama, Y., Hijikata, M., Kageyama, R., Shimotohno, K., Chiba, T. The role of notch signaling in the development of intrahepatic bile ducts. Gastroenterology. 127 (6), 1775-1786 (2004).
  24. Ryback, R., Percarpio, B., Vitale, J. Equilibration and metabolism of ethanol in the goldfish. Nature. 222 (5198), 1068-1070 (1969).
  25. Mathias, J. R., Saxena, M. T., Mumm, J. S. Advances in zebrafish chemical screening technologies. Future Med Chem. 4 (14), 1811-1822 (2012).
  26. Chen, C. H., Durand, E., Wang, J., Zon, L. I., Poss, K. D. zebraflash transgenic lines for in vivo bioluminescence imaging of stem cells and regeneration in adult zebrafish. Development. 140 (24), 4988-4997 (2013).
  27. Westhoff, J. H., et al. Development of an automated imaging pipeline for the analysis of the zebrafish larval kidney. PLoS One. 8 (12), e82137(2013).
  28. Perlman, Z. E., et al. Multidimensional drug profiling by automated microscopy. Science. 306 (5699), 1194-1198 (2004).
  29. Chu, J., Sadler, K. C. New school in liver development: lessons from zebrafish. Hepatology. 50 (5), 1656-1663 (2009).
  30. Choi, T. Y., Ninov, N., Stainier, D. Y., Shin, D. Extensive conversion of hepatic biliary epithelial cells to hepatocytes after near total loss of hepatocytes in zebrafish. Gastroenterology. 146 (3), 776-788 (2014).
  31. He, J., Lu, H., Zou, Q., Luo, L. Regeneration of liver after extreme hepatocyte loss occurs mainly via biliary transdifferentiation in zebrafish. Gastroenterology. 146 (3), 789-800 (2014).
  32. Yao, Y., et al. Fine structure, enzyme histochemistry, and immunohistochemistry of liver in zebrafish. Anat Rec (Hoboken). 295 (4), 567-576 (2012).
  33. Yovchev, M. I., Xue, Y., Shafritz, D. A., Locker, J., Oertel, M. Repopulation of the fibrotic/cirrhotic rat liver by transplanted hepatic stem/progenitor cells and mature hepatocytes. Hepatology. 59 (1), 284-295 (2014).

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Zebrafish Hepatocyte RegenerationHepatic Progenitor CellsChemical Screening ProtocolType One Collagen DepositionEpifluorescent MicroscopyConfocal Imaging AnalysisFatty Acid Binding ProteinMTZ Treatment ProtocolZebrafish Liver Model
Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration
Contact Us
Recommend to Library

Privacy

Terms of Use

Policies

Copyright © 2026 MyJoVE Corporation. All rights reserved.